Results 21 to 30 of about 5,207 (190)

Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?

The Turkish Journal of Gastroenterology, 2017
Besides reducing the reflux symptoms, the benefit of proton pump inhibitors (PPI) in the treatment of Barrett's esophagus (BE) is not exactly known.
Hakan Akın, Yücel Aydın
doaj   +1 more source

Origin of adenocarcinoma in Barrett's esophagus: P53 and Ki67 expression and histopathologic background Origem do adenocarcinoma no esôfago de Barrett: bases histopathológicas e expressão dos genes p53 e Ki67

Clinics, 2005
Barrett's esophagus is the substitution of squamous epithelium of the distal esophagus by columnar epithelium. Intestinal metaplasia in Barrett's esophagus is considered to be the main risk factor for the development of adenocarcinoma.
Sergio Szachnowicz, Ivan Cecconello, Kiyoshi Iriya, Allan Garms Marson, Flávio Roberto Takeda, Joaquim José Gama-Rodrigues   +5 more
doaj   +1 more source

Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. [PDF]

PLoS Genetics, 2011
Although a combination of genomic and epigenetic alterations are implicated in the multistep transformation of normal squamous esophageal epithelium to Barrett esophagus, dysplasia, and adenocarcinoma, the combinatorial effect of these changes is unknown.
Hector Alvarez, Joanna Opalinska, Li Zhou, Davendra Sohal, Melissa J Fazzari, Yiting Yu, Christina Montagna, Elizabeth A Montgomery, Marcia Canto, Kerry B Dunbar, Jean Wang, Juan Carlos Roa, Yongkai Mo, Tushar Bhagat, K H Ramesh, Linda Cannizzaro, J Mollenhauer, Reid F Thompson, Masako Suzuki, Stephen J Meltzer, Ari Melnick, John M Greally, Anirban Maitra, Amit Verma   +23 more
doaj   +1 more source

Prevalence of Barrett's esophagus in individuals without typical symptoms of gastroesophageal reflux disease Prevalência do esôfago de Barrett em indivíduos sem sintomas típicos da doença por refluxo gastroesofágico

Arquivos de Gastroenterologia, 2008
BACKGROUND: Barrett’s esophagus, the major risk factor for esophageal adenocarcinoma, is detected in approximately 10%-14% of individuals submitted to upper endoscopy for the assessment of gastroesophageal reflux disease related symptoms.
Mauro Carneiro de Freitas, Luciana Dias Moretzsohn, Luiz G. V. Coelho   +2 more
doaj   +1 more source

Endoscopic therapy for Barrett′s esophagus

Journal of Digestive Endoscopy, 2012
Barrett’s esophagus (BE) is the precursor lesion to esophageal adenocarcinoma. This cancer has undergone a rapid increase in incidence in Western societies in the last 30 years.
Nicholas J. Shaheen
doaj   +1 more source

Immunoreactivity of cytokeratins 7 and 20 in goblet cells and columnar blue cells in patients with endoscopic evidence of Barrett's esophagus Imunoreatividade das citoqueratinas 7 e 20 nas células caliciformes e células colunares azuis em pacientes com evidência endoscópica de esôfago de Barrett

Arquivos de Gastroenterologia, 2009
CONTEXT: Barrett's esophagus is characterized by the presence of goblet cells. However, when alcian-blue is utilized, another type of cells, called columnar blue cells, is frequently present in the distal esophagus of patients with endoscopic evidence of
João Carlos Cantarelli Jr., Renato Borges Fagundes, Luise Meurer, Marta Pires da Rocha, André Nicola, Cleber Dario Pinto Kruel   +5 more
doaj   +1 more source

Barrett Esophagus [PDF]

Mayo Clinic Proceedings, 2019
Barrett esophagus is a metaplastic change in the lining of the distal esophageal epithelium, characterized by replacement of the normal squamous epithelium by specialized intestinal metaplasia. The presence of Barrett esophagus increases the risk of esophageal adenocarcinoma several-fold.
Prasad G. Iyer, Vivek Kaul
openaire   +2 more sources

O esôfago de Barrett associado à estenose cáustica do esôfago Barrett's esophagus associated to caustic stenosis of the esophagus

Arquivos de Gastroenterologia, 2003
RACIONAL: A estenose esofágica secundária à ingestão de produtos cáusticos é freqüente no Brasil, principalmente como tentativa de suicídio. O esôfago de Barrett surge como conseqüência do refluxo gastroesofágico crônico.
Nelson Adami Andreollo, Luiz Roberto Lopes, Valdir Tercioti Jr., Nelson Ary Brandalise, Luiz Sérgio Leonardi   +4 more
doaj   +1 more source

Barrett's esophagus in childhood [PDF]

Gastroenterology, 1984
This study describes the clinical, radiologic, esophageal function test, endoscopic, and histologic findings of Barrett's esophagus in 11 children aged 6-14 yr. All had long-standing symptoms of gastroesophageal reflux, which had begun in the first year of life in 10 of the 11.
E, Hassall, W M, Weinstein, M E, Ament
openaire   +2 more sources

Progression to cancer in patients with confirmed dysplasia compared to dysplasia downgraded to non-dysplastic metaplasia in Barrett’s esophagus: a retrospective cohort study in Sweden [PDF]

Clinical Endoscopy
Background/Aims This study aimed to clarify the risk of progression in patients with non-dysplastic Barrett’s esophagus (NDBE) and patients with confirmed low-grade dysplasia (LGD) and indefinite for dysplasia (IND) after an expert pathologist review of ...
Peter Elbe, Åke Öst, Lennart Mellbom, Anders Thorell, Bengt Håkanson, Fredrik Klevebro, Mats Lindblad   +6 more
doaj   +1 more source